What Happened?
San Carlos, CA-based Glycomine Appointed Agnes Rafalko as Founder
About the Company
There are approximately 7,000 rare disorders worldwide. Each day more are being discovered. 95% of rare diseases have not one single FDA approved treatment. Glycomine develops therapeutics for diseases which have no treatment options.
About the Person
Agnes Rafalko is Founder at Glycomine. Previously, Agnes held various senior HR leadership roles in the industry.
Info Source
News
Short Profile